Drug Treatment for Pathologic Gambling Disorder

Completed · Phase 3 · Has a placebo group

Conditions studied: Gambling

In brief

This study will establish the best dose of the drug naltrexone to treat patients with Pathological Gambling Disorder (PGD) and severe urge symptoms.

Key facts

Study ID

NCT00053677

Run by

University of Chicago

People needed

83

Starts

2002-12-01

Expected to finish

2005-11-01

Last updated by the study team

2023-02-23

Who can join

Age: 21 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Diagnostic and Statistical Manual IV criteria for Pathological Gambling Disorder
• Moderate or severe gambling urge assessed by the Gambling Symptom Assessment Scale
• No psychiatric drug use for 2 weeks or more
• Score >= 5 on The South Oaks Gambling Screen
• Hamilton Depression Rating Scale and Anxiety Rating score < 26. An increase (up to 10 points) of the scores is allowed unless the subject shows the risks of suicide.
• Completion of complete blood count, urinalysis, liver and thyroid function tests, and pregnancy tests, with no evidence of significant lab abnormalities
• Reliable birth control in women of child-bearing potential

Where it is running

• University of Minnesota Medical School — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.